A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

A Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW1809-T2 and DW1809-1 in Healthy Adult Volunteers

Randomized, Open-label, Oral, Single-dose, two-Sequence, four-Period, crossover study

Inclusion Criteria:

• Healthy Volunteers who are ≥19 years old
• Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2 and

Exclusion Criteria:

• Clinically significant Medical History
• In the case of women, pregnant(Urine-HCG positive) or lactating women